For laboratory research use only · Not for human or veterinary use · 18+
Kits, stacks and value packs

Buy Retatrutide Starter Kit in Australia

Retatrutide 10mg vial, BAC water 3 mL, 10 × 0.5 mL insulin syringes and 20 alcohol swabs · Available to order, dispatched from Australia
$161.99

Buy Retatrutide starter kit in Australia from Macropus Peptides and receive everything needed to open one research vial in a single parcel. The kit holds a Retatrutide 10mg vial of lyophilised powder, a 3 mL vial of bacteriostatic water, ten 0.5 mL insulin syringes and twenty alcohol swabs. The peptide is one synthetic chain that activates the GIP, GLP-1 and glucagon receptors, and 10mg is the strength most laboratories open first. Dissolving it in all of the supplied water gives a stock of about 3.33 mg per mL. Its label carries a lot number, and a certificate of analysis for that lot is available on request. The kit price sits barely above the 10mg vial on its own and well under the four items ordered separately. Order online and the parcel ships from inside Australia to any Australian address. Sold to researchers aged 18 and over for in-vitro laboratory work only, not for human or veterinary use.

1
Frequently bought together
For in-vitro laboratory research only. Not for human or veterinary use. Purchasers must be 18 or over.
KitRetatrutide starter kit
Amountstarter kit
FormResearch kit
ContentsRetatrutide 10mg vial, BAC water 3 mL, 10 × 0.5 mL insulin syringes and 20 alcohol swabs
CategoryKits, stacks and value packs
StorageSee label
TestingHPLC purity 98% or higher and mass spectrometry identity, every batch
Certificate of analysisAvailable for every lot, matched to the lot number on the label

Buy Retatrutide Starter Kit Australia: 10mg Vial, BAC Water, Syringes and Swabs

Macropus Peptides packs this kit for laboratories that want to open one vial of the triple agonist without sourcing anything else. Inside sit the 10mg vial of lyophilised peptide with its lot printed, three millilitres of bacteriostatic water, ten fine insulin syringes with half-millilitre barrels and a stack of twenty swabs. The peptide is the same material sold as our single 10mg vial and comes from the same controlled supply, so a study that begins here can move to larger vials without changing source.

What is in the Retatrutide kit and what the compound is

The four items cover one complete reconstitution. The compound, known by its development code LY3437943, is one engineered chain able to switch on GIP, GLP-1 and glucagon receptors together, hence the label triple agonist. It was designed for metabolic research, has reached phase 3 clinical trials overseas and has no marketing approval anywhere yet. Ten milligrams is the strength most laboratories open first, so the box is built around it.

How Retatrutide works in research

GLP-1 and GIP are gut hormones released after a meal. Each amplifies glucose-dependent insulin output; GLP-1 additionally delays stomach emptying and signals satiety to the hypothalamus. Glucagon pushes the liver the other way, raising glucose output while increasing fat oxidation. The triple agonist carries all three signals, with its greatest potency at the GIP receptor. Modified amino acids resist the enzymes that clear the native hormones within minutes, and a fatty acid side chain binds albumin, stretching its half-life to about six days in human studies. That profile makes it a tool for separating the glucagon contribution from the incretin pair in cell and animal studies.

What the Retatrutide research shows: trials by journal

The published record opened in Cell Metabolism in 2022, with discovery chemistry and first human data in one paper. In 2023 the New England Journal of Medicine carried a 48-week phase 2 trial in adults with obesity, while The Lancet reported a 36-week diabetes study at the same phase. Liver fat was the focus of a Nature Medicine report in 2024. They tracked weight, glycaemic control and hepatic fat, readouts that set up the phase 3 programme now under way. Short write-ups of every paper sit in the Retatrutide research library.

Retatrutide kit specifications

SpecificationDetail
KitRetatrutide starter kit
Amountstarter kit
FormResearch kit
ContentsRetatrutide 10mg vial, BAC water 3 mL, 10 × 0.5 mL insulin syringes and 20 alcohol swabs
CategoryKits, stacks and value packs
StorageSee label
  • 10mg lyophilised peptide, one vial
  • 3 mL bacteriostatic water
  • Ten 0.5 mL insulin syringes
  • Twenty sealed alcohol swabs

An aluminium crimp closes the glass. Printed on the label: the compound, its 10mg strength, the lot and a storage temperature. Quote that lot and we return the certificate of analysis for the batch your vial came from.

Retatrutide price: kit against buying the parts separately

OptionPrice
Retatrutide starter kit$161.99

Bought as four separate listings (the 10mg vial, the 3 mL diluent, a twenty-pack of syringes and a hundred-pack of swabs), the same contents cost roughly a quarter more than the kit. Seen from the other side, the kit saves close to a fifth and costs barely more than the vial alone. The loose boxes do leave spare syringes and swabs, which only matters to a lab opening several vials. For larger programmes the 30mg single vial carries the lowest price per milligram of the triple agonist.

Retatrutide 10mg: the vial in stock inside the box

The vial holds 10 milligrams as a dry white cake and is identical to the single Retatrutide 10mg vial, so a protocol validated with the kit carries across to repeat orders unchanged. Hold it frozen at minus 20 degrees until the day of mixing; refrigeration between two and eight degrees is acceptable for a short wait.

Water, syringes and swabs: the supplies packed with Retatrutide

Bacteriostatic water contains benzyl alcohol, which limits microbial growth when a stopper is punctured repeatedly, so one prepared vial can be sampled across a study. Half-millilitre barrels resolve volumes to 0.01 mL, finer than a 1 mL syringe reads at the low end of its scale. Twenty swabs give a fresh one for each stopper at each of ten sessions.

Where to buy the Retatrutide kit in Australia

  • Sold online at macropuspeptides.com, priced at $161.99
  • Every batch HPLC tested to 98% or higher purity, with identity confirmed by mass spectrometry
  • A certificate of analysis for every lot, matched to the lot number printed on the label
  • Same-day dispatch from Australian stock for orders paid before 2pm AEST on a business day
  • Tracked delivery Australia wide: standard in 2 to 5 working days, express in 1 to 2 working days
  • Payment by PayID or bank transfer, with your order ID as the reference

How to order Retatrutide online

  • Open the starter kit listing
  • Choose how many kits
  • Add extra BAC water if needed
  • Confirm research use at checkout
  • Request your lot certificate

Retatrutide 10mg calculator: bac water and stock strength

Stock strength equals ten milligrams over whatever volume of water goes in.

  • 3 mL, the whole bottle: 3.33 mg per mL
  • 2 mL: 5 mg per mL
  • 1 mL: 10 mg per mL

At 5 mg per mL every unit line on a kit syringe carries 50 micrograms of stock; at the full 3 mL each line carries about 33. Transferring 2 mL with half-millilitre barrels takes four fills, and emptying the bottle takes six. Where a bigger stock volume is wanted, put a bacteriostatic water 10mL bottle in the cart as well.

Is Retatrutide available in Australia

Yes, as research material. The ARTG carries no listing for the triple agonist, the TGA has granted no approval, because phase 3 work is unfinished and no sponsor has lodged a dossier here. Macropus Peptides supplies the kit for in-vitro laboratory research only, to buyers aged 18 and over, never for human or veterinary use. Your compliance officer should read the current Poisons Standard entry against your organisation's licences before the first order.

For sale Australia wide: Retatrutide packs and delivery

Each kit leaves Australian stock for Melbourne, Perth, Hobart or a regional postcode, with no customs step because nothing crosses a border. Longer projects can move up to the three-vial value pack or the 20mg pen kit, and every bundle sits in kits and stacks.

References

  1. LY3437943, a novel triple glucagon, GIP, and GLP-1 receptor agonist for glycemic control and weight loss: from discovery to clinical proof of concept. Cell Metabolism. 2022.
  2. Triple-hormone-receptor agonist retatrutide for obesity: a phase 2 trial. New England Journal of Medicine. 2023.
  3. Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 trial conducted in the USA. The Lancet. 2023.

Scientific content compiled from the peer-reviewed literature above by the Macropus Peptides technical team. Information is provided for research reference only.

Questions about Retatrutide starter kit

Chat on WhatsApp
Retatrutide starter kit$161.99